乳腺癌中的化疗诱导的CA重复DNA片段会触发抗瘤免疫反应
Xiaoqian Zhang1,2, Penghan Huang1,2, Huiping Chen1,2
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Nature immunology
|September 30, 2025
概括
癌症化疗产生DNA碎片,触发不同的免疫反应. 富含氨酸 (CA) 的DNA片段促进抗瘤免疫力,而缺乏CA的DNA片段导致免疫抑制,提供治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 来自癌症治疗的损伤相关分子模式 (DAMPs) 影响抗瘤免疫力,但机制尚不清楚.
- 特定DNA片段特征在免疫调节中的作用需要进一步阐明.
研究的目的:
- 为了研究化疗诱导的DNA片段如何调节抗瘤免疫力.
- 探索丰富的氨酸-腺素 (CA) 与缺乏CA的DNA片段的免疫效应差异.
- 评估CA丰富的DNA片段在增强抗瘤免疫力的治疗潜力.
主要方法:
- 对结合cGAS和AIM2传感器的DNA片段的分析.
- 研究生物分子凝聚物形成和免疫信号通路.
- 在体内研究使用同植PyMT瘤和DNA片段的内注射.
- 对CA丰富DNA与免疫细胞种群的临床相关性分析以及乳腺癌患者的治疗反应.
主要成果:
- 来自MSH2-低瘤的CA-丰富的DNA片段与cGAS结合,形成凝聚物并促进抗瘤免疫力.
- 来自MSH2高瘤的CA贫乏DNA片段与AIM2接触,通过PD-L1和IDO上调导致免疫抑制.
- 在PyMT瘤中,对CA丰富的DNA进行内注射增强了免疫力.
- 从临床角度来看,乳腺癌中较高的CA丰富DNA水平与瘤抗原反应性T细胞的增加和化学疗法反应的改善相关.
结论:
- 具有不同CA含量的瘤DNA片段通过差异性传感器参与 (cGAS与AIM2) 触发相反的免疫反应.
- 富含CA的DNA片段代表了一种有前途的治疗策略,以增强抗瘤免疫力和提高化疗疗效.
- 这项研究揭示了基因组不稳定性,DNA感应和癌症治疗中的免疫调节之间的新联系.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Vaccines
972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K


